Aggelos Banos

[Aggelos Banos @abanos]

@VarvaraParask @NatImmunol Congrats!

[Lupus Hub @lupus_hub]

CONGRESS | #EULAR2025 | PLENARY SESSION
Antonis Fanouriakis, National and Kapodistrian University of Athens, gave a talk about recent advances in #SLE including pathogenesis, treatment strategy and major clinical trials in 2024-2025.
· Genetic burden of SLE may lead to transition from normal to preclinical autoimmunity and an IFN signature predicts progression from ANA positivity to SLE.
· Summary of 2025 ACR guidelines for SLE has been published.
· HCQ was associated with a reduced risk for any CV outcome but there was no protective role in the preeclampsia.
· HCQ continuation during GC withdrawal may help prevent flares.
· Early use of MMF prevents flares.
Achievement of remission and low disease activity is still low with belimumab and anifrolumab in clinical trials.
· Many trials are ongoing to investigate new agents for treating SLE, including CAR T-cell therapy.
Follow our live feed for more updates: https://t.co/fJPOBGgcwh
#RheumTwitter #rheumatology #MedNews #MedEd #MedicalCongress

[Aggelos Banos @abanos]

@dominikosdb Είναι ο προηγούμενος μήνας από τον Απριλιο

[Aggelos Banos @abanos]

@manospontix Πανέξυπνο σχόλιο...

[NBA TV @NBATV]

The @Celtics tribute video for Marcus Smart 👏

[Alexandros Panagiotopoulos @lex_panagiotop]

Promoting EULAR WAD Webinar and @EMEUNET to Greek rheumatology colleagues during a two-day workshop on #vasculitides !!

👉 https://t.co/yWvZ34x2J6

🫸🫷@Ertugrul_cagri #WAD #EULAR #EMEUNET #RMDStories

[Άγγελος Σπηλιόπουλος @Spiliopoulos_A]

Ένας φίλος ψάχνει σπίτι και άκρη για ναρκωτικά. Προσφέρθηκα να τον βοηθήσω Κεταμίνη εδώ.

[Aggelos Banos @abanos]

@Sardanapalusss @dominikosdb That's a loser's attitude.

[Christos Koutsianas @Dr_C_Koutsianas]

Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis | RMD Open (https://t.co/J1m4Zp7Ca2)
#vasculitis #ANCA #rheumatology
@RheumHippo @ThrouNeedlesEye @AlexandrosPan16 @abanos @ChryssaGialou

[Aggelos Banos @abanos]

@ThrouNeedlesEye @Dr_C_Koutsianas @AlexandrosPan16 @xTT8QW3DPXO1aFC Τι παιχταρου είναι α��τή??? Χθες έβλεπα φάσεις!

[Aggelos Banos @abanos]

Excited to share our freshly published work on the transcriptome and molecular clustering of AAVs! Congrats to the team! #boumpasteam
https://t.co/BQAyGZYlzF

[Effie Apostolou @efapostolou29]

Beautiful model for predicting cell-type specific 3D chromatin architecture and critical regulatory elements! Congrats @artsinyc and team! Can't wait to try it on our cells!

[Akis Papantonis @AkisPapantonis]

In science life, many things are celebrated: papers, grants, etc. This is all fine and good, but the pure joy that the new website of our lab has brought me is (almost) unrivalled! Please take a look:

https://t.co/Hmq8OJYwyX

And to those interested in our work, do get in touch.

[Aggelos Banos @abanos]

We are excited to invite you in the 5th Lupus School organized by our lab!! You could also attend it online! #boumbasteam #sle #research #autoimmunedisease
https://t.co/ZP9TQUDlqM

[Aggelos Banos @abanos]

Congrats to the team!
#boumpasteam #Lupus
Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting https://t.co/ISN5xjTNV8 #mdpibiomedicines μέσω @Biomed_MDPI

[Aggelos Banos @abanos]

Happy to participate in this great work.
ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus. #SLE #DNAdamage #Bcells https://t.co/KOFoietb5U

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”

[SYSCID @SYSCID_project]

Congratulations, Neha, and to the whole team behind this excellent work! 🥳👏

[FIBA EuroBasket @EuroBasket]

Let's make this the most viral post of #EuroBasket 2022

[SYSCID @SYSCID_project]

The first day of our #SYSCID symposium was fabulous, including some well-earned time at the beach after all of our hard work!

Now off to day #2!